你即將離開本站

並前往https://www.investegate.co.uk/open-orphan-plc/rns/fda-breakthrough-designation-for-big-pharma-rsv/202202220700113444C/

Open Orphan PLC (ORPH) - InvestEgate

FDA Breakthrough Designation for Big Pharma RSV candidate. Vaccine candidate assessed in successful human challenge trial conducted by hVIVO.

確定！ 回上一頁

查詢 「ORPH FDA」的人也找了：

  1. ORPH FDA approval
    2.
  2. Orphazyme A/S news
    3.
  3. Orphazyme
    4.
  4. FDA IND database
    5.
  5. Orphan drug Act
    6.
  6. ORPH stock
    7.
  7. Orphan FDA
    8.
  8. Orphazyme as adr
    9.